Joy Gumin Department of Neurosurgery The University of Texas MD Anderson Cancer Center Biography Publications Institution JoVE Articles Joy Gumin has not added a biography. If you are Joy Gumin and would like to personalize this page please email our Author Liaison for assistance. Publications Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Regulates Phagocytosis in Glioblastoma Neuro-oncology. Jan, 2024 | Pubmed ID: 38237157 Tumor-specific Polycistronic MiRNA Delivered by Engineered Exosomes for the Treatment of Glioblastoma Neuro-oncology. Feb, 2024 | Pubmed ID: 37847405 Multiomics Analyses Reveal /YBX1-controlled Posttranscriptional Circuits Promoting Glioblastoma Tumorigenesis/radioresistance Science Advances. Aug, 2023 | Pubmed ID: 37540752 Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity Cancer Research Communications. Jun, 2023 | Pubmed ID: 37379361 Comparison of Pharmacological Inhibitors of Lysine-specific Demethylase 1 in Glioblastoma Stem Cells Reveals Inhibitor-specific Efficacy Profiles Frontiers in Neurology. 2023 | Pubmed ID: 37082446 A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin Cancers. Feb, 2023 | Pubmed ID: 36831427 Author Correction: REST Overexpression in Mice Causes Deficits in Spontaneous Locomotion Scientific Reports. Dec, 2022 | Pubmed ID: 36526687 Reshaping the Tumor Microenvironment with Oncolytic Viruses, Positive Regulation of the Immune Synapse, and Blockade of the Immunosuppressive Oncometabolic Circuitry Journal for Immunotherapy of Cancer. Jul, 2022 | Pubmed ID: 35902132 Characterization of Patient-derived Bone Marrow Human Mesenchymal Stem Cells As Oncolytic Virus Carriers for the Treatment of Glioblastoma Journal of Neurosurgery. Mar, 2022 | Pubmed ID: 34450587 Measuring the Metabolic Evolution of Glioblastoma Throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance Cells. Oct, 2021 | Pubmed ID: 34685601 Targeting the αv Integrin/TGF-β Axis Improves Natural Killer Cell Function Against Glioblastoma Stem Cells The Journal of Clinical Investigation. Jul, 2021 | Pubmed ID: 34138753 An Immune-competent, Replication-permissive Syrian Hamster Glioma Model for Evaluating Delta-24-RGD Oncolytic Adenovirus Neuro-oncology. Nov, 2021 | Pubmed ID: 34059921 Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma Cancer Discovery. Nov, 2021 | Pubmed ID: 34039636 RNAi Technology Targeting the Fusion Breakpoint: an Opportunity for Precision Medicine Neuro-oncology Advances. 2020 | Pubmed ID: 33241214 Advances in Endovascular Neuro-oncology: Endovascular Selective Intra-arterial (ESIA) Infusion of Targeted Biologic Therapy for Brain Tumors Journal of Neurointerventional Surgery. Feb, 2020 | Pubmed ID: 31676690 GITRL-armed Delta-24-RGD Oncolytic Adenovirus Prolongs Survival and Induces Anti-glioma Immune Memory Neuro-oncology Advances. 2019 | Pubmed ID: 31608328 Microcatheter Delivery of Neurotherapeutics: Compatibility with Mesenchymal Stem Cells Journal of Neurosurgery. Sep, 2019 | Pubmed ID: 31491769 REST-DRD2 Mechanism Impacts Glioblastoma Stem Cell-mediated Tumorigenesis Neuro-oncology. Jun, 2019 | Pubmed ID: 30953587 REST Overexpression in Mice Causes Deficits in Spontaneous Locomotion Scientific Reports. Aug, 2018 | Pubmed ID: 30108242 A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Dec, 2018 | Pubmed ID: 30054278 A Gene Expression Signature Predicts Recurrence-free Survival in Meningioma Oncotarget. Mar, 2018 | Pubmed ID: 29662628 Glioblastoma Stem Cell-derived Exosomes Induce M2 Macrophages and PD-L1 Expression on Human Monocytes Oncoimmunology. 2018 | Pubmed ID: 29632728 Magnetic Resonance and Photoacoustic Imaging of Brain Tumor Mediated by Mesenchymal Stem Cell Labeled with Multifunctional Nanoparticle Introduced Via Carotid Artery Injection Nanotechnology. Apr, 2018 | Pubmed ID: 29438105 Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. May, 2018 | Pubmed ID: 29432077 Dexamethasone-mediated Oncogenicity in Vitro and in an Animal Model of Glioblastoma Journal of Neurosurgery. Dec, 2018 | Pubmed ID: 29328002 Mesenchymal Stem Cells As Natural Biofactories for Exosomes Carrying MiR-124a in the Treatment of Gliomas Neuro-oncology. Feb, 2018 | Pubmed ID: 29016843 Ionizing Radiation Augments Glioma Tropism of Mesenchymal Stem Cells Journal of Neurosurgery. Jan, 2018 | Pubmed ID: 28362237 Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, As a Single Agent and in Combination with Temozolomide Against Malignant Gliomas Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2017 | Pubmed ID: 28679777 Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma Molecular Cancer Therapeutics. Apr, 2017 | Pubmed ID: 28138026 A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients Journal of Neurosurgical Anesthesiology. Jan, 2017 | Pubmed ID: 27653222 Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens PloS One. 2016 | Pubmed ID: 27093696 Soluble Tie2 Overrides the Heightened Invasion Induced by Anti-angiogenesis Therapies in Gliomas Oncotarget. Mar, 2016 | Pubmed ID: 26910374 Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell Xenografts Journal of Proteome Research. Sep, 2015 | Pubmed ID: 26185906 Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway Stem Cells (Dayton, Ohio). Aug, 2015 | Pubmed ID: 25966666 ESI-MS/MS and MALDI-IMS Localization Reveal Alterations in Phosphatidic Acid, Diacylglycerol, and DHA in Glioma Stem Cell Xenografts Journal of Proteome Research. Jun, 2015 | Pubmed ID: 25880480 Two Mature Products of MIR-491 Coordinate to Suppress Key Cancer Hallmarks in Glioblastoma Oncogene. Mar, 2015 | Pubmed ID: 24747968 Delta-24-RGD Oncolytic Adenovirus Elicits Anti-glioma Immunity in an Immunocompetent Mouse Model PloS One. 2014 | Pubmed ID: 24827739 TGF-β Mediates Homing of Bone Marrow-derived Human Mesenchymal Stem Cells to Glioma Stem Cells Cancer Research. Apr, 2013 | Pubmed ID: 23365134 REST Regulates Oncogenic Properties of Glioblastoma Stem Cells Stem Cells (Dayton, Ohio). Mar, 2012 | Pubmed ID: 22228704 Author Spotlight: Advancing Glioblastoma Treatment Through Intraarterial Delivery Strategies for Oncolytic Viruses and MicroRNAs Daniel Ledbetter1, Joy Gumin1, Lynette Phillips1, Chibawanye Ene1, Yuzaburo Shimizu1,2, Frederick F. Lang1 1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, 2Department of Neurosurgery, Juntendo University JoVE 66303 Cancer Research
Author Spotlight: Advancing Glioblastoma Treatment Through Intraarterial Delivery Strategies for Oncolytic Viruses and MicroRNAs Daniel Ledbetter1, Joy Gumin1, Lynette Phillips1, Chibawanye Ene1, Yuzaburo Shimizu1,2, Frederick F. Lang1 1Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, 2Department of Neurosurgery, Juntendo University JoVE 66303 Cancer Research
